Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/006908

Recurrent alternative splicing isoform switches in tumor samples provide novel signatures of cancer

Endre Sebestyén·Michał Zawisza·Eduardo Eyras
View original source ↗Export metadata ↓

Abstract

Cancer genomics has been instrumental to determine the genetic alterations that are predictive of various tumor conditions. However, the majority of these alterations occur at low frequencies, motivating the need to expand the catalogue of cancer signatures. Alternative pre-mRNA splicing alterations, which bear major importance for the understanding of cancer, have not been exhaustively studied yet in the context of recent cancer genome projects. In this article we analyze RNA sequencing data for more than 4000 samples from The Cancer Genome Atlas (TCGA) project, including paired normal samples, to detect recurrent alternative splicing isoform switches in 9 different cancer types. We first investigate whether alternative splicing isoform changes are predictive of tumors by applying a rank-based algorithm based on the reversal of the relative expression of transcript isoforms. We find that consistent alternative splicing isoform changes can separate with high accuracy tumor and normal samples, as well as some cancer subtypes. We then searched for those changes that occur in the most abundant isoform, i.e isoform switches, and are therefore more likely to have a functional impact. In total we detected 244 isoform switches, which are associated to functional pathways that are frequently altered in cancer and also separate tumor and normal samples accurately. We further assessed whether these isoform changes are associated to somatic mutations. Surprisingly, only a few cases appear to have association, including the putative tumor suppressor FBLN2 and the tumor driver MYH11, which show association of an isoform switch to mutations and indels on the alternatively spliced exon. However, the number of observed mutations is in general not sufficient to explain the frequency of the found isoform switches, suggesting that recurrent isoform switching in cancer is mostly independent of somatic mutations. In summary, we present an effective approach to detect novel alternative splicing signatures that are predictive of tumors. Moreover, the same methodology has led to uncover recurrent isoform switches in tumors, which may provide novel prognostic and therapeutic targets.\n\nSoftware and data are available at: https://bitbucket.org/regulatorygenomicsupf/iso-ktsp and http://dx.doi.org/10.6084/m9.figshare.1061917

Source connections

Explore related subjects

BioinformaticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Endre Sebestyén, Michał Zawisza, Eduardo Eyras. 2014-07-04. Recurrent alternative splicing isoform switches in tumor samples provide novel signatures of cancer. https://doi.org/10.1101/006908

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2019

Detection and assembly of novel sequence insertions using Linked-Read technology

MotivationEmerging Linked-Read (aka read-cloud) technologies such as the 10x Genomics Chromium system have great potential for accurate detection and phasing of largescale human genome structural variations (SVs). By leveraging the long-range information encoded in Linked-Read sequencing, computational techniques are able to detect and characterize complex structural variations that are previously undetectable by short-read methods. However, there is no available Linked-Read method for detection and assembly of novel sequence insertions, DNA sequences present in a given sequenced sample but missing in the reference genome, without requiring whole genome de novo assembly. In this paper, we propose a novel integrated alignment-based and local-assembly-based algorithm, Novel-X, that effectively uses the barcode information encoded in Linked-Read sequencing datasets to improve detection of such events without the need of whole genome de novo assembly. We evaluated our method on two haploid human genomes, CHM1 and CHM13, sequenced on the 10x Genomics Chromium system. These genomes have been also characterized with high coverage PacBio long-reads recently. We also tested our method on NA12878, the wellknown HapMap CEPH diploid genome and the child genome in a Yoruba trio (NA19240) which was recently studied on multiple sequencing platforms. Detecting insertion events is very challenging using short reads and the only viable available solution is by long-read sequencing (e.g. PabBio or ONT). Our experiments, however, show that Novel-X finds many insertions that cannot be found by state of the art tools using short-read sequencing data but present in PacBio data. Since Linked-Read sequencing is significantly cheaper than long-read sequencing, our method using Linked-Reads enables routine large-scale screenings of sequenced genomes for novel sequence insertions. AvailabilitySoftware is freely available at https://github.com/1dayac/novel_insertions Contactimh2003@med.cornell.edu Supplementary informationSupplementary data are available at https://github.com/1dayac/novel_insertions_supplementary

Bioinformatics↗
bioRxiv2016

iCARE: An R Package to Build and Apply Absolute Risk Models

This report describes a R package, called the Individualized Coherent Absolute Risk Estimation (iCARE) tool, that allows researchers to build and evaluate models for absolute risk and apply them to estimate an individuals risk of developing disease during a specified time interval based on a set of user defined input parameters. An attractive feature of the software is that it gives users flexibility to update models rapidly based on new knowledge on risk factors and tailor models to different populations by specifying three input arguments: (1) a model for relative risk, (2) an age-specific disease incidence rate, (3) the distribution of risk factors for the population of interest. The tool can handle missing information on risk factors for individuals for whom risks are to be predicted using a coherent approach where all estimates are derived from a single model after appropriate model averaging. The software allows single nucleotide polymorphisms (SNPs) to be incorporated into the model using published odds ratios and allele frequencies. The validation component of the software implements the methods for evaluation of model calibration, discrimination and risk-stratification based on independent validation datasets. We provide an illustration of the utility of iCARE for building, validating and applying absolute risk models using breast cancer as an example.

Bioinformatics↗
bioRxiv2016

deSPI: efficient classification of metagenomic reads with lightweight de Bruijn graph-based reference indexing

SummaryIn metagenomic studies, fast and effective tools are on wide demand to implement taxonomy classification for upto billions of reads. Herein, we propose deSPI, a novel read classification method that classifies reads by recognizing and analyzing the matches between reads and reference with de Bruijn graph-based lightweight reference indexing. deSPI has faster speed with relatively small memory footprint, meanwhile, it can also achieve higher or similar sensitivity and accuracy.\n\nAvailabilitythe C++ source code of deSPI is available at https://github.com/hitbc/deSPI\n\nContactydwang@hit.edu.cn\n\nSupplementary informationSupplementary data are available at Bioinformatics online.

Bioinformatics↗